The ‘Bumetanide Tablets Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability position, ...

The company stated that they are prepared to begin shipping product to wholesalers in early February 2018. Upsher-Smith Laboratories has received approval from the Food and Drugs Administration (FDA) ...

Bumetanide comes in the form of a tablet to be taken once a day. It can be taken either with food or on an empty stomach. In case bumetanide causes stomach upset, it should be taken only with food. If ...

This medication is a diuretic, prescribed for the treatment of swelling and fluid retention due to congestive heart failure, liver and kidney disease.

New Delhi, May 2 (PTI) Zydus Cadila today said it has received final approval from the US health regulator to market Bumetanide tablets used for treatment of edema caused by conditions such as heart ...

Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon as practical. The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of ...

Bumetanide nasal spray had comparable pharmacodynamic effects of diuresis and natriuresis to IV and oral bumetanide. (HealthDay News) — Bumetanide nasal spray (BNS) has statistical bioequivalence to ...